Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ABVC ABVC BioPharma > Detailed Quotes

ABVC ABVC BioPharma

Watchlist
0.717
-0.013-1.78%
Trading Session  01/31 11:48 ET
High
0.759
Open
0.746
Turnover
23.02K
Low
0.710
Pre Close
0.730
Volume
31.72K
Market Cap
23.40M
P/E(TTM)
Loss
52wk High
3.130
Shares
32.63M
P/E(Static)
Loss
52wk Low
0.500
Float Cap
12.19M
Bid/Ask %
66.67%
Historical High
11.690
Shs Float
17.01M
Volume Ratio
1.20
Historical Low
0.500
Dividend TTM
--
Div Yield TTM
--
P/B
3.96
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.19%
Amplitude
6.67%
Avg Price
0.725
Lot Size
1
Float Cap
12.19M
Bid/Ask %
66.67%
Historical High
11.690
Shs Float
17.01M
Volume Ratio
1.20
Historical Low
0.500
Dividend TTM
--
P/B
3.96
Dividend LFY
--
Turnover Ratio
0.19%
Amplitude
6.67%
Avg Price
0.725
Lot Size
1
Price Forecast

News

Comment

Company Overview More
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.
CEO: Mr. Howard Doong
Market: NASDAQ
Listing Date: 08/03/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist